Regeneron Pharmaceuticals (REGN) - 26 Year Stock Price History

Historical daily stock prices for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Regeneron Pharmaceuticals (REGN) as of November 17, 2017 is 391.59.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $41.959B $4.860B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)